Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2024-02-16 00:00:00 ET · period of report 2024-02-15 · accession 0001415889-24-004106 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-16 | 2024-02-15 | PTCT | Klein Matthew B. | CEO, Dir | A - Grant | $0.00 | +70.0K | 230.5K | +44% | $0 |
| D | 2024-02-16 | 2024-02-15 | PTCT | Klein Matthew B. | CEO, Dir | A - Grant | $0.00 | +175.0K | 175.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-15 | A | A | 70,000 | $0.00 | 230,475 | D | — | — | (F1) Restricted stock units granted on February 15, 2024 that vest in four equal installments over four years, commencing on February 15, 2025. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-02-15 | A | A | 175,000 | $0.00 | 175,000 | D | $25.69 · — to 2034-02-14 | 175,000 Common Stock | (F2) This option was granted on February 15, 2024, and vests over four years, with 25% of the shares underlying the option vesting on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025. |